Austrade is promoting the Australian clinical trials industry.
Phase 2 trials typically cost 28pc less to conduct in Australia than in the US, Austrade reports.
When tax incentives are included, the advantage increases to 60pc.
"Overseas biopharma companies are also attracted by Australia’s advanced medical research environment, rapid trial approvals and robust regulatory framework.
"With over 50 clinical research networks and bio labs, Australia typically hosts 1,300 clinical trials each year."
- Forums
- ASX - By Stock
- CTE
- Clinical Trial News
Clinical Trial News, page-3
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CTE (ASX) to my watchlist
|
|||||
Last
$1.13 |
Change
0.000(0.00%) |
Mkt cap ! $55.15M |
Open | High | Low | Value | Volume |
$1.13 | $1.13 | $1.13 | $170 | 150 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4484 | $1.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.12 | 3614 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4444 | 1.125 |
1 | 3738 | 1.070 |
1 | 10000 | 1.050 |
1 | 2000 | 1.030 |
1 | 22000 | 0.980 |
Price($) | Vol. | No. |
---|---|---|
1.120 | 3614 | 1 |
1.130 | 6 | 1 |
1.165 | 26333 | 1 |
1.200 | 1101 | 1 |
1.250 | 36037 | 2 |
Last trade - 11.15am 09/07/2024 (20 minute delay) ? |
Featured News
CTE (ASX) Chart |